Cong-fei Xu
Guangzhou, 511442, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Engineering Interferon-γ-Enhanced Chimeric Antigen Receptor Macrophages via Lipid-Assisted Polymeric Nanoparticles for Cancer Immunotherapy.
Journal: ACS nano
Published: July 04, 2026
In vivo production of CAR-T cells using virus-mimetic fusogenic nanovesicles.
Journal: Science bulletin
Published: May 11, 2023
Progress in nanoparticle-based regulation of immune cells.
Journal: Medical review (2021)
Published: December 24, 2022
In Situ Programming of Nanovaccines for Lymph Node-Targeted Delivery and Cancer Immunotherapy.
Journal: ACS nano
Published: August 26, 2022
HSP70-Promoter-Driven CRISPR/Cas9 System Activated by Reactive Oxygen Species for Multifaceted Anticancer Immune Response and Potentiated Immunotherapy.
Journal: ACS nano
Published: August 22, 2022
Delivery of mRNA for regulating functions of immune cells.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: December 03, 2021
Biomaterials-Based Delivery of Therapeutic Antibodies for Cancer Therapy.
Journal: Advanced healthcare materials
Published: December 06, 2020
Dually regulating the proliferation and the immune microenvironment of melanoma via nanoparticle-delivered siRNA targeting onco-immunologic CD155.
Journal: Biomaterials science
Published: October 22, 2020
Corrigendum to "Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells" [Biomaterials 37 (2015) 405-414].
Journal: Biomaterials
Published: September 16, 2020
Last Updated: 09/26/2026